AI assistant
Sending…
BioInvent International — Major Shareholding Notification 2011
Jul 1, 2011
3011_iss_2011-07-01_318014ef-7715-42e8-a7a2-1c6a30cee0e5.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer BioInvent International Aktiebolag
Holder
Avanza Bank Holding AB
Instrument
| Instrument | Aktier |
|---|---|
| Before the transaction | |
| Shares | 3,074,239 |
| Voting rights | 3,074,239 |
| Transaction | |
| Reason for major shareholding notification New share issue | |
| Date | 30/06/2011 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 3,080,298 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 3,080,298 |
| Percentage | |
| Directly held shares | 4.58 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.58 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares |
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total
Group total holdings
Voting rights 3,080,298 Percentage of voting rights 4.58
Notes (other relevant informations according to law)
Aktierna innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt innehar de aktuella aktierna.
Published
01/07/2011 14:23
Contact
Name Tanya Forsstedt
Phone 08-56225737 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from BioInvent International
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 29
AGM Information
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 24
Proxy Solicitation & Information Statement
2026
Mar 24
Interim / Quarterly Report
2026
Feb 26